Related Experiment Video
Updated: Aug 23, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Cell therapy for ischemic heart disease
1Department of Cardiac Surgery, University of Innsbruck, Innsbruck, Austria. nikolaos.bonaros@uibk.ac.at
Abstract:
Despite advances in pharmacological therapies, cardiovascular surgery, use of mechanical assist devices, and organ transplantation, more than 50% of the patients with clinically evident heart failure die within 5 years of the initial diagnosis. The use of cellular therapy offers a promising approach for both the prevention and treatment of heart failure. This review will discuss the current state of this emerging field and the prospects to introduce the method into clinical practice. Since functional restoration of the damaged heart presents a formidable challenge, developing strategies for the prevention of postinfarct heart failure remains of utmost priority. Recent research has provided evidence that several cell lines including adult or embryonic stem cells, skeletal myoblasts, fetal cardiomyocytes or fibroblasts may be useful in strategies that aim to both prevent and treat heart failure through establishment of new blood vessels supplying surviving heart muscle cells and replacement of damaged heart muscle cells themselves. It is therefore reasonable to anticipate that new strategies will be developed to optimize cell delivery, homing and survival in the failing myocardium improving myocardial recovery after acute or chronic deterioration.
Insights
Cellular therapy shows promise for preventing and treating heart failure, offering new hope for patients. Research explores optimizing cell delivery and survival to improve heart muscle recovery.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Cell Biology
Background:
- Heart failure remains a leading cause of mortality, with over 50% of patients dying within five years of diagnosis despite current treatments.
- Functional restoration of the damaged heart is a significant challenge, highlighting the need for novel therapeutic strategies.
Purpose of the Study:
- To review the current status of cellular therapy for heart failure.
- To explore the potential of cell-based approaches for preventing and treating heart failure.
- To discuss prospects for clinical implementation of cellular therapies.
Main Methods:
- Review of recent research on various cell types, including stem cells, skeletal myoblasts, fetal cardiomyocytes, and fibroblasts.
- Analysis of strategies for preventing post-infarction heart failure.
- Examination of cell delivery, homing, and survival in the myocardium.
Main Results:
- Several cell lines demonstrate potential for preventing and treating heart failure.
- Cellular therapies may promote new blood vessel formation (angiogenesis) and replace damaged heart muscle cells.
- Optimizing cell delivery, homing, and survival is crucial for myocardial recovery.
Conclusions:
- Cellular therapy presents a promising avenue for heart failure management.
- Further research is needed to optimize cell-based strategies for clinical application.
- Successful implementation could significantly improve outcomes for patients with heart failure.
More Related Videos
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
11:51Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Published on: March 1, 2016
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Cardiomyopathy V: Interprofessional Care
Myocarditis III: Medical Management
Stem Cell Culture